Handling of cationic antigens in the joint and induction of chronic allergic arthritis. In vivo studies in the rat.
The aims of the present study were to define, under in vivo conditions, factors governing antigen binding and persistence in the rat joint and to establish a chronic arthritis model by means of a natural polycation. The influence of size as well as charge on antigen handling was examined using a range of chemically cationized proteins and natural polycations. Arthritis was induced by intraarticular challenge in preimmunized rats. Immunofluorescence studies revealed that not only pI, which must exceed pH 8-9, but also molecular size was a decisive parameter: only antigens of more than 40 kD were able to persist for significant periods in joint structures. All existing models of antigen induced chronic arthritis in rodents utilize chemically cationized proteins. We extended this system to natural polycations by showing that lysozyme (pI 11.3; MW 14 kD) in tetrameric, charge conserved form (MW 56 kD) as a model-antigen was able to induce chronic arthritis in the rat. After intraarticular challenge of preimmunized animals the course of inflammation was assessed both by 99mTechnetium-pertechnetate (99mTc) scintigram and from the histology. In contrast to monomeric lysozyme, which evoked only a transient inflammatory response (less than two weeks), tetrameric lysozyme induced a chronic arthritis, which still persisted at day 90. Our results show that the ability of cationic antigens to trigger chronic arthritis is vitally size dependent. This is also the first report of a natural polycation acting as an arthritogen, thus providing an experimental basis justifying the search for cationic microbial antigens in human post infectious reactive arthritis.
Gondolf
K B
KB
Department of Immunology, University of Freiburg, Federal Republic of Germany.
Batsford
S
S
Lässle
G
G
Curschellas
E
E
Mertz
A
A
D000818:Animals; D000941:Antigens; D001168:Arthritis / Q000139:chemically induced / Q000276:immunology*; D002412:Cations / Q000276:immunology / Q000494:pharmacology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D007719:Knee Joint / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D008297:Male; D008970:Molecular Weight; D009113:Muramidase / Q000276:immunology / Q000494:pharmacology*; D011506:Proteins; D051381:Rats; D011919:Rats, Inbred Strains
D000941:Antigens; D002412:Cations; D011506:Proteins; D009113:Muramidase